Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
0.8524
-0.0201 (-2.30%)
At close: Dec 5, 2025, 4:00 PM EST
0.8430
-0.0094 (-1.10%)
After-hours: Dec 5, 2025, 7:31 PM EST
Equillium Market Cap
Equillium has a market cap or net worth of $51.91 million as of December 5, 2025. Its market cap has increased by 115.12% in one year.
Market Cap
51.91M
Enterprise Value
20.24M
1-Year Change
115.12%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $51.91M, a decrease of -77.87%. That is a compound annual growth rate of -19.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 53.13M | 100.42% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | 132.29M | 125.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |